Cargando…

Correction to: A noninvasive model to predict liver histology for antiviral therapy decision in chronic hepatitis B with alanine aminotransferase < 2 upper limit of normal

Detalles Bibliográficos
Autores principales:	Chen, Shanshan, Huang, Haijun, Huang, Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7934402/ https://www.ncbi.nlm.nih.gov/pubmed/33663375 http://dx.doi.org/10.1186/s12876-021-01649-0

Ejemplares similares

A noninvasive model to predict liver histology for antiviral therapy decision in chronic hepatitis B with alanine aminotransferase < 2 upper limit of normal
por: Chen, Shanshan, et al.
Publicado: (2021)

Clinical Non-invasive Model to Predict Liver Inflammation in Chronic Hepatitis B With Alanine Aminotransferase ≤ 2 Upper Limit of Normal
por: Chen, Shanshan, et al.
Publicado: (2021)

Upper Limits of Normal for Serum Alanine Aminotransferase Levels in Chinese Han Population
por: Zheng, Ming-Hua, et al.
Publicado: (2012)

Updated upper limit of normal for serum alanine aminotransferase value in Vietnamese population
por: Huong, Nguyen Thi Cam, et al.
Publicado: (2022)

Upper Normal Limits of Serum Alanine Aminotransferase in Healthy Population: A Systematic Review
por: Kolahdoozan, Shadi, et al.
Publicado: (2020)

Determination of the upper limits of normal serum alanine aminotransferase (ALT) level in healthy Turkish population
por: Degertekin, Bulent, et al.
Publicado: (2020)

Histological and Clinical Characteristics of Patients with Chronic Hepatitis C and Persistently Normal Alanine Aminotransferase Levels
por: Roshan, Bakht, et al.
Publicado: (2014)

A Mechanistic Assessment of the Discordance between Normal Serum Alanine Aminotransferase Levels and Altered Liver Histology in Chronic Hepatitis B
por: Gong, Xianqiong, et al.
Publicado: (2015)

A promising non-invasive index for predicting liver inflammation in chronic hepatitis B patients with alanine aminotransferase ≤2 upper limit of normal
por: Yu, Xue-Ping, et al.
Publicado: (2018)

Upper Normal Limit of Serum Alanine Aminotransferase and Its Association with Metabolic Risk Factors in Pars Cohort Study
por: Sehatpour, Faeze, et al.
Publicado: (2020)

Antiviral Therapy for Chronic HBV Infection With Persistently Normal Alanine Aminotransferase: Controversy and Consensus
por: Zhou, Jing, et al.
Publicado: (2021)

Hepatitis C Virus Clearance by Direct-acting Antiviral Results in Rapid Resolution of Hepatocytic Injury as Indicated by Both Alanine Aminotransferase and Aspartate Aminotransferase Normalization
por: Huynh, Tung, et al.
Publicado: (2018)

Alanine Aminotransferase Level: The Road to Normal in 2021
por: Yip, Terry Cheuk‐Fung, et al.
Publicado: (2021)

Clinical impact of normal alanine aminotransferase on direct‐acting antiviral outcome in patients with chronic hepatitis C virus infection
por: Joshita, Satoru, et al.
Publicado: (2019)

A Noninvasive Score to Predict Liver Fibrosis in HBeAg-Positive Hepatitis B Patients with Normal or Minimally Elevated Alanine Aminotransferase Levels
por: Chen, Yanping, et al.
Publicado: (2018)

Non-ALT biomarkers for markedly abnormal liver histology among Chinese persistently normal alanine aminotransferase-chronic hepatitis B patients
por: Cheng, Jin-Lin, et al.
Publicado: (2017)

Lowering the upper limit of serum alanine aminotransferase levels may reveal significant liver disease in the elderly
por: Schmilovitz-Weiss, Hemda, et al.
Publicado: (2019)

Development and Validation of a Non-invasive Model to Predict Liver Histological Lesions in Chronic Hepatitis B Patients With Persistently Normal Alanine Aminotransferase and Detectable Viremia
por: Hu, Qiankun, et al.
Publicado: (2022)

Significant Histologic Changes Are Not Rare in Treatment-naive Hepatitis B Patients with Normal Alanine Aminotransferase Level: A Meta-analysis
por: Zhang, Chi, et al.
Publicado: (2021)

Spleen thickness can predict significant liver pathology in patients with chronic hepatitis B with persistently normal alanine aminotransferase or minimally raised alanine aminotransferase: a retrospective study
por: Zhang, Junli, et al.
Publicado: (2018)

Early Normalization of Alanine Aminotransferase during Antiviral Therapy Reduces Risk of Hepatocellular Carcinoma in HBV Patients
por: Kim, Sehwa, et al.
Publicado: (2021)

Clinical Features of Hepatitis C Virus Carriers With Persistently Normal Alanine Aminotransferase Levels
por: Uto, Hirofumi, et al.
Publicado: (2012)

Correction: Elevated Aspartate and Alanine Aminotransferase Levels and Natural Death among Patients with Methamphetamine Dependence
por: Kuo, Chian-Jue, et al.
Publicado: (2012)

Correction: Elevated Aspartate and Alanine Aminotransferase Levels and Natural Death among Patients with Methamphetamine Dependence
por: Kuo, Chian-Jue, et al.
Publicado: (2012)

Normal Limit for Serum Alanine Aminotransferase Level and Distribution of Metabolic Factors in Old Population of Kalaleh, Iran
por: Kabir, Ali, et al.
Publicado: (2013)

Effectiveness of antiviral treatment in HBeAg-negative chronic hepatitis B patients with normal or mildly elevated alanine aminotransferase: a retrospective study
por: Wei, Sufang, et al.
Publicado: (2022)

Expression Pattern of Serum Cytokines in Hepatitis B Virus Infected Patients with Persistently Normal Alanine Aminotransferase Levels
por: He, Dengming, et al.
Publicado: (2013)

Markedly Elevated Serum Aspartate Aminotransferase to Alanine Aminotransferase Ratio: A Clue to Hepatic Neoplasia
por: Lee, Brian T., et al.
Publicado: (2020)

Plasma Sphingolipids as Potential Indicators of Hepatic Necroinflammation in Patients with Chronic Hepatitis C and Normal Alanine Aminotransferase Level
por: Li, Jun-Feng, et al.
Publicado: (2014)

Alanine aminotransferase to aspartate aminotransferase ratio and hepatitis B virus on metabolic syndrome: a community-based study
por: Lin, Ming-Shyan, et al.
Publicado: (2022)

Chronic Hepatitis C: Acute Exacerbation and Alanine Aminotransferase Flare
por: Kanda, Tatsuo, et al.
Publicado: (2023)

Aspartate Aminotransferase (AST/GOT) and Alanine Aminotransferase (ALT/GPT) Detection Techniques
por: Huang, Xing-Jiu, et al.
Publicado: (2006)

Aspartate aminotransferase/alanine aminotransferase ratio and subsequent cancer development
por: Kobayashi, Daiki, et al.
Publicado: (2021)

The Role of Metabolic Factors and Steatosis in Treatment-Naïve Patients with Chronic Hepatitis B and Normal Alanine Aminotransferase
por: Diao, Yuting, et al.
Publicado: (2022)

Predictors for advanced liver fibrosis in chronic hepatitis B virus infection with persistently normal or mildly elevated alanine aminotransferase
por: Wang, Dexin, et al.
Publicado: (2017)

Effectiveness of Tenofovir Alafenamide in Chronic Hepatitis B Patients with Normal Alanine Aminotransferase and Positive Hepatitis B Virus DNA
por: Gao, Wen-Kang, et al.
Publicado: (2022)

Serum hepatitis B core antibody as a biomarker of hepatic inflammation in chronic hepatitis B patients with normal alanine aminotransferase
por: Zhou, Jiyuan, et al.
Publicado: (2017)

Diagnostic value of FIB-4, aspartate aminotransferase-to-platelet ratio index and liver stiffness measurement in hepatitis B virus-infected patients with persistently normal alanine aminotransferase
por: Tan, You-Wen, et al.
Publicado: (2017)

Low aspartate aminotransferase/alanine aminotransferase (DeRitis) ratio assists in predicting diabetes in Chinese population
por: Xie, Wangcheng, et al.
Publicado: (2022)

The value of aspartate aminotransferase and alanine aminotransferase in cardiovascular disease risk assessment
por: Weng, Stephen F, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_iu11p90rubk5f7ukivbla7mqge